Skip to main content
. 2019 Nov 4;11(11):576. doi: 10.3390/pharmaceutics11110576

Table 3.

In Vitro deposition tests—emitted dose (ED), fine particle dose (FPD), and fine particle fraction (FPF) of salbutamol sulphate from ternary mixtures of α-lactose monohydrate (Lα·H2O), salbutamol sulphate (SS), and variable percentages (10%, 30%, and 50% w/w) of micronized lactose in comparison with a binary mixture containing no micronized lactose (M-SS). Mean values ± standard deviation (n = 5).

Mixture ED (µg) FPD (µg) FPF (%)
M-SS 177.1 ± 3.4 26.8 ± 1.9 15.1 ± 0.8
M-10 178.7 ± 4.6 84.3 ± 2.6 47.2 ± 0.7
M-30 180.9 ± 9.7 103.4 ± 7.3 57.2 ± 2.5
M-50 102.8 ± 5.5 34.9 ± 4.6 33.9 ± 2.8